Tokyo, Japan

Masashi Akitsu

This inventor holds 1 USPTO granted patent. Top assignees: Japan Bio Products Co., Ltd., The Doshisha. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masashi Akitsu. Retrieved from https://idiyas.com/inventor/masashi-akitsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masashi Akitsu: Innovator in Ocular Disease Treatment

Introduction

Masashi Akitsu is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of ocular diseases. His innovative approach has led to the development of a unique medicament aimed at preventing and treating conditions such as dry eye.

Latest Patents

Masashi Akitsu holds a patent for a drug designed to prevent or treat ocular diseases. This medicament comprises cyclo-trans-4-L-hydroxyprolyl-L-serine as its active ingredient. The invention specifically addresses dry eye by enhancing mucin secretion and promoting the repair of ocular tissue damage caused by this condition. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Akitsu has worked with reputable organizations, including Japan Bio Products Co., Ltd. and Doshisha University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in ocular health.

Collaborations

Masashi Akitsu has collaborated with notable colleagues such as Taiichi Kaku and Yoshiharu Kadota. These partnerships have contributed to the development of innovative solutions in the medical field.

Conclusion

Masashi Akitsu's work in developing treatments for ocular diseases highlights his dedication to improving patient care. His innovative contributions continue to influence the medical community and pave the way for future advancements in ocular health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…